PPT2 expression was found to be reduced in ccRCC samples and low levels correlate with poor survival,95 whereas in ccRCC cell lines PPT2 overexpression reduced EMT, cell migration, and invasion. This evidence concerns the gene PPT2 and nonpapillary renal cell carcinoma.